246 related articles for article (PubMed ID: 11802924)
1. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
Conant MA; Schacker TW; Murphy RL; Gold J; Crutchfield LT; Crooks RJ;
Int J STD AIDS; 2002 Jan; 13(1):12-21. PubMed ID: 11802924
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.
Bodsworth NJ; Crooks RJ; Borelli S; Vejlsgaard G; Paavonen J; Worm AM; Uexkull N; Esmann J; Strand A; Ingamells AJ; Gibb A
Genitourin Med; 1997 Apr; 73(2):110-6. PubMed ID: 9215092
[TBL] [Abstract][Full Text] [Related]
3. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
4. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
5. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
6. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
Johnston C; Saracino M; Kuntz S; Magaret A; Selke S; Huang ML; Schiffer JT; Koelle DM; Corey L; Wald A
Lancet; 2012 Feb; 379(9816):641-7. PubMed ID: 22225814
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
8. Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
Pinder M; Wright A
Int J STD AIDS; 2015 Nov; 26(13):971-3. PubMed ID: 25505043
[TBL] [Abstract][Full Text] [Related]
9. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
Patel R; Bodsworth NJ; Woolley P; Peters B; Vejlsgaard G; Saari S; Gibb A; Robinson J
Genitourin Med; 1997 Apr; 73(2):105-9. PubMed ID: 9215091
[TBL] [Abstract][Full Text] [Related]
10. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
11. Valaciclovir: new indications. In genital herpes: simpler administration.
Prescrire Int; 1999 Feb; 8(39):8-9. PubMed ID: 10557565
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
13. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
14. [Valaciclovir].
Lebrun-Vignes B
Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):708-15. PubMed ID: 12124513
[TBL] [Abstract][Full Text] [Related]
15. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
[TBL] [Abstract][Full Text] [Related]
16. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
Reitano M; Tyring S; Lang W; Thoming C; Worm AM; Borelli S; Chambers LO; Robinson JM; Corey L
J Infect Dis; 1998 Sep; 178(3):603-10. PubMed ID: 9728526
[TBL] [Abstract][Full Text] [Related]
17. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
18. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir.
Strand A; Patel R; Wulf HC; Coates KM;
Sex Transm Infect; 2002 Dec; 78(6):435-9. PubMed ID: 12473805
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
[TBL] [Abstract][Full Text] [Related]
20. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
